Form 4: Tempus AI Director Peter Barris Awarded 5,913 RSUs

Director Peter J. Barris received a grant of 5,913 restricted stock units as part of his compensation, increasing his total holdings in Tempus AI.

Summary

• Peter J. Barris, a director at Tempus AI, Inc., was granted 5,913 Class A Common Stock restricted stock units (RSUs) on May 21, 2026.
• The RSUs are scheduled to vest in full on the earlier of the 2027 annual meeting of stockholders or May 21, 2027.
• Following this transaction, Peter Barris directly owns a total of 121,424 shares of Class A Common Stock.
• The grant was issued at a price of $0.00 as part of standard director compensation.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine administrative filing. While it shows continued director commitment, it is a standard compensation event rather than a strategic shift.

Positives

• Director interests remain aligned with shareholders through equity-based compensation.
• Peter Barris maintains a significant stake in the company with over 121,000 shares owned directly.

Negatives

• The grant represents potential future dilution, though minimal at 5,913 shares.

Risks

• Vesting is contingent upon the reporting person's continuous service with the company through May 2027.
• The ultimate value of the award is subject to market volatility and the performance of Class A Common Stock.

Future Outlook

The granted RSUs will vest in full by May 2027, assuming continued service on the board, further solidifying the director's long-term equity position in the company.

Industry Context

StockSavvy.ai notes that equity-based compensation for directors is a standard practice among high-growth AI and healthcare technology firms to ensure board members are incentivized to drive long-term shareholder value.

Comparison to Industry Standards

• The RSU grant size is consistent with director compensation packages at peer precision medicine and AI companies such as Guardant Health and Illumina.
• Vesting schedules of one year for director grants are typical for Nasdaq-listed technology companies.

Corporate Governance

Stakeholder Impact

• Shareholders may view the continued equity participation of board members as a sign of confidence in the company's long-term trajectory.

Next Steps

• Vesting of 5,913 RSUs on or before May 21, 2027.

Key Dates

Recommendation

This filing reflects a routine compensation event for a director and does not provide new material information regarding the company's operational performance or financial health that would warrant a change in investment thesis.

Keywords

Tempus AI, TEM, Peter Barris, SEC Form 4, Insider Trading, Restricted Stock Units, Director Compensation, Class A Common Stock